Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
4.200
+0.060 (1.45%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $10.34 million as of October 15, 2025. Its market cap has increased by 193.86% in one year.
Market Cap
10.34M
Enterprise Value
9.15M
1-Year Change
193.86%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has increased from $5.88M to $10.34M, an increase of 75.95%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 10.19M | 197.86% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | 11.03M | 19.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 746.02B |
| Johnson & Johnson | 457.13B |
| AbbVie | 406.31B |
| UnitedHealth Group | 322.88B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 229.74B |